Supporters say consumers should be protected from unknowingly eating material from novel vaccines, which are similar to COVID ...
Over the last three years, the FDA has approved six new hemophilia drugs, including three gene therapies. | Over the last ...
Phase 1 clinical trial of CMP-CPS-001 in Urea Cycle Disorders (UCDs) ongoing, with dosing completed in two of four multiple ascending dose ...
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, today announced 2024 results and 2025 guidance. For the full year ending ...
Net Loss: The net loss attributable to Serina for the year ended December 31, 2024 was $11.1 million, or $ (1.51) per basic and diluted share, compared to net income of $5.3 million, or $2.36 per ...
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today highlighted the significance of the U.S. Food and Drug Administration's (FDA) approval of Qfitliatm (fitusiran), the sixth ...
Ring-shaped extrachromosomal DNA is implicated in many cancers. Rachel Brazil talks to the scientists trying to uncover their ...
1d
Study Finds on MSNThis Evolutionary Mistake Made Horses Into World-Class AthletesUncover the secrets of race horses and how a genetic mutation enhances their endurance and energy during intense exercise.
Strongrevenueperformance,includingapproximately$1.9millionmilestoneandlicenserevenuerecognizedin2024Up to $7.5 million in grants awarded from ...
Q4 2024 Earnings Call Transcript March 26, 2025 Dyadic International, Inc. misses on earnings expectations. Reported EPS is $ ...
Merck signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion.
There will be plenty of trucks, cars and bikes on display, with show awards taking place across all three vehicle categories.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results